H5N1 bird flu is becoming endemic: "Present or usually prevalent in a population or geographical area at all times, said of a disease or agent."
However, Big Pharma won't produce H5N1 vaccines for the world market.
So Vietnam and Russia are taking matters into their own hands and planning to produce their own bird flu vaccine supplies.
Vietnam to produce human H5N1 vaccines
Thursday, Mar 2, 2006 - Vietnam will start manufacturing human vaccines against bird flu virus strain H5N1 in late 2006 with initial annual capacity of between two to three million doses, an official in charge of hygiene and epidemiology said yesterday.
A human H5N1 vaccine production line has already been installed at the National Institute of Hygiene and Epidemiology, the official from the institute told Xinhua on condition of anonymity.
The institute's initial vaccine production capacity is able to serve some one million people.
***
Hungarian firm may build bird flu vaccine plant in Russia
BUDAPEST. March 2 (Interfax) - The Hungarian-based Serbolab Company is considering the construction of a bird flu vaccine plant in Russia, Chelyabinsk regional economic development minister Yury Klepov told a Thursday press conference in Budapest.
The $30 million plant might be built in the Chelyabinsk region, he said. The Hungarian Export-Import Bank may fund the project, he added.


